Universal Aspirin in High-Risk Pregnancies?
Conexiant
February 11, 2026
Universal aspirin dispensation at the first prenatal visit reduced preeclampsia with severe features by 29% in high-risk pregnancies.
The study involved 18,457 patients before and after aspirin implementation, showing a decrease in severe preeclampsia rates from 7% to 5%.
Aspirin administration also led to a decline in gestational hypertension rates from 21% to 19% and reduced preterm delivery before 37 weeks.
Postpartum hemorrhage rates decreased from 9.5% to 8.9%, and placental abruption rates remained stable at less than 1%.
The findings suggest aspirin may delay or prevent severe preeclampsia, but results may not generalize to other populations.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
Editor
Affiliations:
Specialties:
Areas of Expertise: